In this study, we evaluated GP73 expression by immunohistochemistry (IHC) on a tissue microarray containing 348 gastric cancer tumor tissues, and tried to investigate the expression of GP73 and its relationship with pathological response in patients with neoadjuvant chemotherapy as well as prognosis in patients with gastric cancer. This evidence concerns the gene GOLM1 and gastric cancer.